Clinical Trial Update: Chemotherapy for Lung Cancer in HIV-positive Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing chemotherapy for non-small cell lung cancer in HIV-positive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Non-small Cell Lung Cancer, Hiv-positive | Phase 2 | Status: COMPLETED